Page 127 - DUOKOPT BIBLIOBOOK
P. 127

EFFICACY










                  Januleviciene et al





                  two including impaired autoregulation within the OAG pop-  MATERIALS AND METHODS
                  ulation (4). Liu et al (5) showed that abnormal hemodynam-
                  ics can affect the blood supply to the optic disc and retina   Thirty patients with OAG were recruited for a 1-year study.
                  in primary OAG (POAG). Visual field damage progression   We performed a prospective, randomized, double masked,
                  further correlated with retrobulbar hemodynamic variables,   parallel study. All subjects read and signed an informed
                  independent of the extent of glaucomatous damage and   consent, and the study was approved by Kaunas University
                  intraocular pressure (6).                 of Medicine’s institutional review board. The study eye was
                  Although we have growing evidence to suggest that pa-  chosen randomly. Glaucoma was defined by characteristic
                  tients with glaucoma have reduced blood flow to the retina,   glaucomatous visual field loss, optic nerve head damage,
                  choroid, and optic nerve, we do not have clear evidence   and IOP greater than or equal to 21 mmHg, as determined
                  on the clinical relevance of these finding in terms of visual   by Goldmann applanation tonometry without treatment
                  function. Visual field testing is considered to be the gold   (14). Included were patients with OAG over 18 years old
                  standard for glaucoma diagnosis and follow-up, but it has   who were willing to sign an informed consent statement
                  distinct limitations. Histologic studies have found that as   and able to comply with the requirements of the examina-
                  many as half of all ganglion cells can be lost before a de-  tions. Visual acuity requirements included best-corrected
                  fect is detected by the visual field (7). Furthermore, visual   visual acuity of 0.5 or better. Exclusion criteria included
                  field examinations have a high variability of results. Almost   mean deviation greater than or equal to –12 dB in Hum-
                  86% of the defects detected with standard automated pe-  phrey visual field central 30-2. We also excluded patients
                  rimetry are not replicated on repeated testing (8).  with cup to disc ratio equal to or greater than 0.9, history
                  One of the major hallmarks of glaucoma is loss in retinal   of eye disease other than refractive error, orbital or ocular
                  ganglion cells and as a consequence loss in nerve fiber   trauma, and history of renal or hepatic disease, asthma, or
                  layers. Apoptosis of retinal ganglion cells has been con-  respiratory disease, or allergy to either of the study medi-
                  sidered the most plausible pathogenic mechanism of glau-  cations. Pregnant or nursing women were excluded.
                  coma. Apoptosis can be caused by neurotrophic factor   Patients were instructed to avoid caffeine intake, smoking, and
                  withdrawal or glutamate release and both are triggered   exercise for 3 hours prior to each study visit. All study visits were
                  by elevated IOP and ischemia, simultaneously or sepa-  scheduled at the same time of day ±1 hour in order to avoid di-
                  rately (9). Nerve fiber layer (NFL) thinning was reported to   urnal fluctuations in IOP and arterial blood pressure (BP).
                  precede visual function loss and optic disc changes (10,   Patients were given timolol bid for 4 weeks run-in period
                  11). Scanning laser polarimetry is one of the techniques   before study entry. After 4 weeks of timolol treatment, we
                  to measure peripapillary NFL thickness. Evaluation of the   randomly assigned patients to treatment Group A or B (15
                  retinal NFL (RNFL) may facilitate and support the clinical   patients in each group): Group A received topical treatment
                  course of glaucoma.                       with DTFC bid (morning and bedtime) while Group B re-
                  Multiple IOP lowering medications are frequently required to   ceived topical treatment with LTFC qid (morning time).
                  achieve adequate control of IOP. Fixed combination treat-  Examinations were carried out at baseline and at 1, 6, and
                  ments provide effective IOP control with the advantages   12 months of treatment. Each study visit included adverse
                  of improved patient compliance and without the washout   events check, BP measurements with a calibrated mercury
                  effect of multiple drops (12). Vorwerk et al (13) suggested   sphygmomanometer, and radial pulse rate measurements
                  that treatment alterations are necessary to achieve suffi-  taken by palpation for a 60-second time interval. Ocular
                  cient IOP control. By prescribing more aggressive thera-  perfusion (OP) was calculated as 2/3 of mean arterial blood
                  pies as outlined by treatment guidelines, including fixed   pressure minus IOP; diastolic perfusion pressure (DPP) was
                  combination preparations, both efficacy and compliance   calculated as diastolic blood pressure minus IOP; systolic
                  of the patients may be improved.          perfusion pressure (SPP) was calculated as systolic blood
                  The aim of our study was to compare IOP-lowering ef-  pressure minus IOP (15).
                  fect  of latanoprost/timolol (LTFC)  versus dorzolamide/  Measurements included full ophthalmic examination, visual
                  timolol (DTFC) fixed combinations and to investigate   acuity, Goldmann IOP, central corneal thickness (CCT) (OcuS-
                  their effects on ocular hemodynamics and structural   can PXP, Alcon Labs. Inc.), Humphrey visual field examina-
                  and functional changes in patients with glaucoma after   tion (central 30-2), and scanning laser polarimetry (GDx VCC
                  1 year of follow-up.                      Laser Diagnostic Technologies Inc., San Diego, CA). Ocular

                                                                                                791


             EJO_790-797_Janule.indd   791                                                      3-08-2009   14:04:14






                                                                                                                   127
   122   123   124   125   126   127   128   129   130   131   132